牛市氛围浓厚，港A股齐涨，上证指数创10年新高，港股主要指数上涨。 恒生创新药继续上涨，恒生创新药ETF(159316)今日涨超3.3%，自今年3月底上市以来涨76.5%，净值创上市以来新高。 恒生创新药ETF是全市场目前唯一跟踪恒生港股通创新药指数的ETF，聚焦高业务纯度、高弹性标的，成份股包括石药集团、中国生物制药、康方生物、百济神州、信达生物、三生制药等港股前沿创新药企，支持T+0交易。 值得一提的是，恒生港股通创新药指数成分股调整近期已实施，移除CXO企业，修订后创新药成分含量100%，纯度直接拉满。 恒生创新药ETF(159316)持续得到资金关注，今年下半年以来资金净流入额6.63亿元，最新规模12.58亿元，规模较今年3月底上市以来增长357%。 对于创新药赛道，天风证券表示，考虑到创新药密集兑现期到来，国家政策支持力度持续明确，创新药产业发展趋势及产业升级主线已经较明确。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.